How best to manage the patient in term labor whose group B strep status is unknown? by Brooke, Shannon et al.
CLINICAL INQUIRIES
Evidence Based Answers 
from the Family Physicians 
Inquiries Network
42 VOL 58, NO 1 / JANUARY 2009  THE JOURNAL OF FAMILY PRACTICE
FAST TRACK
  
How best to manage the patient 
in term labor whose group B 
strep status is unknown?
Shannon Brooke, MD  
James Whitworth, PhD
Eglin Air Force Base Family 
Medicine Residency,  
Eglin AFB, Fla
Nancy Calabretta, MS, MEd
Cooper University Hospital, 
Camden, NJ
The CDC  
recommends  
screening for GBS 
by culture at 35 to 
37 weeks for most 
women 
Monitor the patient and treat her with 
intrapartum chemoprophylaxis based 
on identi!ed risk factors, unless a rapid, 
highly sensitive (≥85%) polymerase chain 
reaction (PCR) test is immediately available 
to evaluate for group B Streptococcus 
(GBS) (strength of recommendation: B, 
inconsistent or limited quality evidence). 
Evidence-based answer
❚ Evidence summary
GBS infection is a leading cause of neo-
natal bacteremia, pneumonia, and men-
ingitis.1 Approximately 10% to 30% of 
pregnant women are colonized with GBS 
in the vagina or rectum.2,3 Giving intra-
partum antibiotics to women at high risk 
for GBS colonization (TABLE 1) has sig-
ni!cantly reduced the incidence of neo-
natal sepsis, from approximately 2 cases 
to 0.5 cases per 1000 live births.1,3 
Universal screening is the way to go
A multistate retrospective cohort study 
(N=5144) concluded that universal 
screening by culture for GBS at 35 to 37 
weeks’ gestation is more effective than 
treating patients based on risk-factor 
criteria (relative risk [RR]=0.46; 95% 
con!dence interval [CI], 0.36-0.60).4 The 
Centers for Disease Control and Preven-
tion’s (CDC) 2002 revised guidelines rec-
ommend universal screening by culture 
at 35 to 37 weeks, with 2 exceptions: 
women who had GBS bacteriuria dur-
ing the current pregnancy and women 
who have given birth to an infant with 
invasive GBS disease.5 The GBS status of 
5% to 10% of term patients remains un-
known at onset of labor because of inad-
equate prenatal care or out-of-date GBS 
culture results (>5 weeks).6,7 
PCR is the most accurate  
rapid test for GBS
A 2006 systematic review of 29 prospec-
tive studies found the PCR test to be the 
most accurate rapid assessment for GBS 
status at onset of labor.8 The test was 
96% sensitive (95% CI, 0.88-0.99) and 
98% speci!c (95% CI, 0.96-0.99) com-
pared with optical immunoassay, DNA 
hybridization, enzyme immunoassay, 
latex agglutination, and Islam starch 
medium tests (TABLE 2).8 Culture, usu-
ally on selective media, was the gold 
standard. 
The rapid PCR test takes about 40 
minutes, making it useful to determine 
the need for antibiotic prophylaxis 
in laboring, full-term, GBS-status-un-
known women. If a rapid PCR test isn’t 
available, a woman with unknown GBS 
status and 1 or more of the CDC risk 
factor criteria should receive intrapar-
tum antibiotics.5
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Chlorhexidine has no effect
Vaginal disinfection with chlorhexidine 
during delivery has been used to prevent 
GBS transmission, but no highly con-
trolled trials have demonstrated a ben-
e!t or consequence of this approach. A 
systematic review of 5 randomized and 
quasi-randomized, variable-quality tri-
als comparing vaginal disinfection with 
chlorhexidine with placebo found no sta-
tistically signi!cant reduction in early-on-
set neonatal GBS sepsis (RR=2.32; 95% 
CI, 0.34-15.63), pneumonia (RR=0.35; 
95% CI, 0.01-8.60), or meningitis 
(RR=0.35; 95% CI, 0.01-8.60).9 
Recommendations
The American College of Obstetricians 
and Gynecologists, the American Acad-
emy of Pediatrics, and the CDC recom-
mend screening all pregnant women at 35 
to 37 weeks’ gestation and administering 
prophylaxis to all GBS carriers.5,10 They 
also advocate intrapartum antibiotic 
prophylaxis for pregnant women whose 
GBS status is unknown and who have a 
risk factor for GBS listed in TABLE 1.5,10 
Rapid tests to detect GBS when status is 
unknown should replace the risk-based 
approach only if the test has a sensitivity 
of at least 85%.5 ■
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Risk factors for GBS
Temperature >100.4ºF 
Rupture of membranes >18 hours 
Preterm labor <37 weeks
GBS bacteriuria anytime during pregnancy
Previous infant with early-onset GBS infection
GBS, group B Streptococcus.
Source: 2002 CDC guidelines5 in consensus with the American Academy of Pediatrics 
and the American College of Obstetrics and Gynecology.
TABLE 1
How accurate are intrapartum tests for GBS?
TEST LR+ LR– 
TYPICAL  
DURATION (MIN)
Rapid PCR 38.8 0.06 40-100
Optical immunoassay 16.01 0.35 30
DNA hybridization NA NA 60-1440
Enzyme immunoassay 9.37 0.78 5-10
Latex agglutination 83.18 0.43 70-85
Islam starch medium 28.33 0.57 120-1400
GBS, group B Streptococcus; LR+, positive likelihood ratio; LR–, negative likelihood 
ratio; PCR, polymerase chain reaction. 
Tests with an LR >10 effectively rule in disease; tests with an LR <0.1 effectively rule 
out disease. 
Source: Honest H et al.8
TABLE 2
